Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54

United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026

Add to watchlist

By person

9 insiders · 33 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Herriot Tabuteau

Chief Executive Officer

—

$75.99M (11) scheduled

−$75.99M

7,229

0.0138%

$1.51M

0.0%

Nick Pizzie

Chief Financial Officer

—

$10.18M (2) scheduled

−$10.18M

42,867

0.0818%

$8.94M

0.0%

Mark L. Jacobson

Chief Operating Officer

—

$8.90M (4) scheduled

−$8.90M

0.0000%

$0.00

−100.0%

Mark Coleman

Director

—

$8.21M (5) scheduled

−$8.21M

30,389

0.0580%

$6.34M

+108.1%

Mark E Saad

Director

—

$6.21M (2) scheduled

−$6.21M

11,431

0.0218%

$2.39M

+14.3%

Ari Maizel

Chief Commercial Officer

—

$2.75M (2) scheduled

−$2.75M

0.0000%

$0.00

—

Susan Mahony

Director

—

$145.02K (2) scheduled

−$145.02K

829

0.0016%

$172.97K

—

Roger Jeffs

Director

—

$141.66K (2) scheduled

−$141.66K

58,367

0.1114%

$12.18M

−65.2%

Hunter R. Murdock

General Counsel

—

0.0000%

$0.00

—

Axsome Therapeutics, Inc.

What the insiders did Scheduled selling only

By person